BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 17904412)

  • 1. Taking aim on bacterial pathogens: from phage therapy to enzybiotics.
    Hermoso JA; García JL; García P
    Curr Opin Microbiol; 2007 Oct; 10(5):461-72. PubMed ID: 17904412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage endolysins--current state of research and applications.
    Loessner MJ
    Curr Opin Microbiol; 2005 Aug; 8(4):480-7. PubMed ID: 15979390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic diversity and cell wall binding repeats in the phage-encoded endolysins.
    Broendum SS; Buckle AM; McGowan S
    Mol Microbiol; 2018 Dec; 110(6):879-896. PubMed ID: 30230642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls.
    Korndörfer IP; Danzer J; Schmelcher M; Zimmer M; Skerra A; Loessner MJ
    J Mol Biol; 2006 Dec; 364(4):678-89. PubMed ID: 17010991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.
    Yoong P; Schuch R; Nelson D; Fischetti VA
    J Bacteriol; 2004 Jul; 186(14):4808-12. PubMed ID: 15231813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an endolysin, LysBPS13, from a Bacillus cereus bacteriophage.
    Park J; Yun J; Lim JA; Kang DH; Ryu S
    FEMS Microbiol Lett; 2012 Jul; 332(1):76-83. PubMed ID: 22524239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endolysins as antimicrobials.
    Nelson DC; Schmelcher M; Rodriguez-Rubio L; Klumpp J; Pritchard DG; Dong S; Donovan DM
    Adv Virus Res; 2012; 83():299-365. PubMed ID: 22748813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL.
    Briers Y; Volckaert G; Cornelissen A; Lagaert S; Michiels CW; Hertveldt K; Lavigne R
    Mol Microbiol; 2007 Sep; 65(5):1334-44. PubMed ID: 17697255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.
    Oliveira H; São-José C; Azeredo J
    Viruses; 2018 May; 10(6):. PubMed ID: 29844287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics.
    Rodríguez-Rubio L; Martínez B; Donovan DM; Rodríguez A; García P
    Crit Rev Microbiol; 2013 Nov; 39(4):427-34. PubMed ID: 22991936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage lytic enzymes: novel anti-infectives.
    Fischetti VA
    Trends Microbiol; 2005 Oct; 13(10):491-6. PubMed ID: 16125935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.
    Jado I; López R; García E; Fenoll A; Casal J; García P;
    J Antimicrob Chemother; 2003 Dec; 52(6):967-73. PubMed ID: 14613958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phage lytic enzymes--new hope in battle against bacterial infections].
    Niczyporuk JS; Bartoszcze M
    Przegl Epidemiol; 2007; 61(4):713-21. PubMed ID: 18572503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci.
    Donovan DM; Foster-Frey J
    FEMS Microbiol Lett; 2008 Oct; 287(1):22-33. PubMed ID: 18673393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.
    Gondil VS; Harjai K; Chhibber S
    Int J Antimicrob Agents; 2020 Feb; 55(2):105844. PubMed ID: 31715257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into the binding and catalytic mechanisms of the Listeria monocytogenes bacteriophage glycosyl hydrolase PlyP40.
    Romero P; Bartual SG; Schmelcher M; Glück C; Hermoso JA; Loessner MJ
    Mol Microbiol; 2018 Apr; 108(2):128-142. PubMed ID: 29405497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Lytic Enzymes.
    Briers Y
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30699900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage endolysins as a novel class of antibacterial agents.
    Borysowski J; Weber-Dabrowska B; Górski A
    Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listeria bacteriophage peptidoglycan hydrolases feature high thermoresistance and reveal increased activity after divalent metal cation substitution.
    Schmelcher M; Waldherr F; Loessner MJ
    Appl Microbiol Biotechnol; 2012 Jan; 93(2):633-43. PubMed ID: 21720825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.